YenZym Antibodies

YenZym Antibodies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.3M

Overview

YenZym Antibodies operates as a specialized contract research organization (CRO) providing custom antibody generation services to the global life sciences research community. The company's key differentiator is its deep expertise in designing antigens for difficult-to-target proteins, such as GPCRs and ion channels, and its focus on producing antibodies specific to a wide array of post-translational modifications. Led by an experienced immunologist, Dr. Yen, the firm leverages over 25 years of cumulative experience to offer tailored immunization regimens, positioning itself as a problem-solving partner for academic and industrial researchers. Its business model is entirely service-based, generating revenue from project fees for custom antibody development.

Antibodies

Technology Platform

Expert-led methodology for custom antigen design and tailored immunization regimens, specializing in antibodies against post-translational modifications (PTMs) and difficult protein targets like GPCRs.

Funding History

2
Total raised:$2.3M
Grant$500K
Seed$1.8M

Opportunities

Growing demand for PTM-specific antibodies in proteomics and epigenetics research provides a strong tailwind.
The company's niche expertise and publication record position it well to capture high-value projects from academic and pharmaceutical clients who cannot find suitable commercial reagents.
There is an opportunity to form strategic service partnerships with larger biopharma companies.

Risk Factors

High dependence on founder expertise and reputation creates key-person risk.
Competition from larger reagent companies and technological shifts towards recombinant antibody platforms threaten the traditional polyclonal service model.
The business is vulnerable to reductions in global research and development funding.

Competitive Landscape

YenZym competes in the fragmented custom antibody services market against large reagent suppliers (e.g., Thermo Fisher, Abcam), university core facilities, and other specialized CROs. Its differentiation lies in its deep focus on challenging PTM and membrane protein targets and its high-touch, expert-led project design, rather than competing on high-throughput or low-cost production.